Shaping the future of diabetes care - Roche

More documents

Recommendations

Info

Monitoring and therapy delivery are converging r Disetronic’s pump technology a key component Insulin Delivery Blood Glucose Monitoring Syringe Strips Pens Pump Meters and Strips Integrated Strips Systems today future Pump/ blood Glucose Meter Communication Open-loop Automated Pancreas Closed-loop Automated Pancreas Insulin Algorithm Continuous Monitoring 10
Roche adding marketing and sales muscle to penetrate US market Animas 1 % * top 13 countries US market 2001 Disetronic 17 % Medtronic/ Minimed 82 % total: CHF 550 m non-US market 2001 Disetronic 70 % total: CHF 160 m Medtronic/ Minimed 30 % total market* 2001: CHF 710 million with approximately 11 % growth p.a. r 11
Page 1 and 2: Shaping the future of diabetes care
Page 3 and 4: The idea Roche Diagnostics, the wor
Page 5 and 6: Strategic rationale Shaping the fut
Page 7 and 8: Diabetes: a problem of epidemic pro
Page 9: Glucose monitoring and insulin deli
Page 13 and 14: Entry into insulin pump market Grow
Page 15 and 16: Disetronic, the world’s No. 2 in
Page 17 and 18: Business model with two elements br
Page 19 and 20: Proposed transaction structure r Ef
Page 21 and 22: Transaction multiples based upon th
Page 23 and 24: Public tender offer on Disetronic s
Page 25 and 26: About Roche Diabetes Care • Pione
Page 27 and 28: Diabetes is not curable, but it is

Shaping the future of diabetes care - Roche

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?